Answers are grounded in this paper and cite their sources.
This commentary highlights that diverse cardioprotective signaling pathways converge on the phosphorylation and inhibition of GSK-3β to prevent mitochondrial permeability transition and subsequent apoptosis during ischemia/reperfusion.
Numerous signaling pathways have been shown to mediate cardioprotection, but the end effectors that mediate protection are only beginning to be elucidated.Numerous cardioprotective drugs are shown to converge on glycogen synthase kinase-3 (GSK-3) (see the related article beginning on page 1535).The phosphorylation and inhibition of GSK-3 lead to inhibition or delayed activation of the mitochondrial permeability transition, a key regulator of apoptosis.Nonstandard abbreviations used: adenine nucleotide translocator (ANT); glycogen synthase kinase (GSK); mitochondrial ATP-dependent K + [channel] (mitoKATP); mitochondrial permeability transition (MPT); Na + -H + exchange (NHE); preconditioning (PC); reactive oxygen species (ROS); voltage-dependent anion channel (VDAC).
No takes yet. Share an insight, caveat, or question.
Elizabeth Murphy (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: